Down Syndrome and Sleep Apnea Study (DOSA)
Contact
Description
This research study is being conducted to look at oxygen as a treatment of obstructive sleep apnea (OSA) in children with Down syndrome. The main reason for the study is to show how 6 months of oxygen treatment while sleeping affects the participants sleep, quality of life, breathing, heart and if it makes the participant feel better.
Eligibility and criteria
IRB Number:
23-021397
Eligible age range:
Clinical trial phase:
Phase II
Official title:
What to expect
Related specialties
Related conditions
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.